CalciMedica, Inc..
CALC.US | N/A
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release...Show More
Better Health for All
0
No evidence available to assess CalciMedica, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics.
1
Its core business does not involve providing financial services such as lending, deposits, or insurance to consumers.
2
The provided articles discuss stock offerings, financial results (cash, R&D expenses, net loss), and clinical trial developments. There is no evidence in the articles pertaining to any of the KPIs under the 'Fair Money & Economic Opportunity' value, which are designed for financial institutions or companies with financial service offerings. Therefore, all KPIs are omitted due to a lack of relevant data.
Fair Pay & Worker Respect
0
No specific, quantifiable evidence regarding CalciMedica, Inc.'s performance on living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage was found in the provided articles. The articles primarily contain financial data or regulatory filing information without details on worker-related metrics. While employee benefit plans are mentioned.
1
no data on the percentage of the workforce covered by specific benefits like health insurance or the prevalence of insecure contracts is provided. Similarly, statements about the absence of regulatory actions in a specific filing do not constitute comprehensive evidence of zero labor violations across all operations for the past three years.
2
Fair Trade & Ethical Sourcing
0
No evidence available to assess CalciMedica, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess CalciMedica, Inc. on Honest & Fair Business.
Kind to Animals
-50
CalciMedica, a biopharmaceutical company, conducts preclinical studies using rat models for its therapeutic candidate, Auxora.
1
The company used rat models to study Auxora's effects on acute kidney injury (AKI), administering Auxora intravenously to rats at 16 mg/kg over 4 hours, with assessments at 6, 24, 48, and 72 hours after ischemia/reperfusion.
2
The article does not provide a publicly available animal testing policy, indicating a lack of transparency regarding the company's stance on animal welfare in testing. While the company uses animals in its testing, the exact number of animals used annually is not disclosed, making it difficult to assess the volume precisely. However, the use of rat models for preclinical studies suggests a reliance on animal testing.
3
No War, No Weapons
0
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for inflammatory and immunologic processes.
1
The company is not involved in arms or defense contracts, dual-use technologies, or sales to embargoed regimes.
2
Its core business does not include peacebuilding or disarmament initiatives, conflict-related activities, defense-related business, or lobbying related to arms control.
3
The company is not involved in procurement related to humanitarian aid, operations in conflict-affected areas, or the arms trade.
4
It does not develop AI for military applications, nor does it have exposure to human-rights risks or controversial weapons.
5
There is no evidence of involvement in surveillance contracts, war-risk supply chains, or conflict-linked partnerships.
6
The company's business model does not involve mineral inputs or technology development related to peace or military applications.
7
Planet-Friendly Business
0
No evidence available to assess CalciMedica, Inc. on Planet-Friendly Business.
Respect for Cultures & Communities
0
No information regarding CalciMedica, Inc.'s performance on any of the 'Respect for Cultures & Communities' KPIs was found in the provided articles. The articles primarily consist of SEC filing lists, a LinkedIn post about a conference, and a company overview of its research, none of which contain specific data points related to community engagement, cultural impact, or local investment.
Safe & Smart Tech
0
No evidence available to assess CalciMedica, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
The provided articles discuss general trends, challenges, and potential solutions for sustainable pharmaceutical packaging and waste management within the industry. However, none of the articles contain specific, quantitative data or concrete actions directly attributable to CalciMedica, Inc. (CALC.US) for any of the KPIs related to Zero Waste & Sustainable Products.
1
Therefore, no KPIs can be scored based on the evidence provided.